Dietary broccoli lessens development of fatty liver and liver cancer in mice given diethylnitrosamine and fed a western or control diet

Journal of Nutrition

Volumn 146, Issue 3, 2016, Pages 542-550

  Chen, Yung Ju ^a   Wallig, Matthew A ^a   Jeffery, Elizabeth H ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Broccoli; Diethylnitrosamine; Liver cancer; NAFLD; Western diet

Indexed keywords

ALANINE AMINOTRANSFERASE; CD36 ANTIGEN; CD68 ANTIGEN; DIETHYLNITROSAMINE; LARD; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; SATURATED FATTY ACID; SUCROSE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROCCOLI; CONTROLLED STUDY; DIET; DIET THERAPY; DISEASE COURSE; DOWN REGULATION; FOOD INTAKE; GENE EXPRESSION; LIPID LIVER LEVEL; LIPID METABOLISM; LIPIDOSIS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MACROPHAGE ACTIVATION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; UPREGULATION; WESTERN DIET; ADVERSE EFFECTS; ANIMAL; BLOOD; BRASSICA; CHEMICALLY INDUCED; LIVER; LIVER TUMOR; METABOLISM;

ALANINE TRANSAMINASE; ANIMALS; BRASSICA; CARCINOMA, HEPATOCELLULAR; DIET, WESTERN; DIETHYLNITROSAMINE; LIPID METABOLISM; LIVER; LIVER NEOPLASMS; MALE; MICE; NON-ALCOHOLIC FATTY LIVER DISEASE; TRIGLYCERIDES;

EID: 84960324427     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.228148     Document Type: Article

References (69)

1. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science 2011;332:1519-23.
2. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124-31.
3. World Health Organization. Liver cancer: estimated incidence, mortality and prevalence worldwide in 2012 [Internet]. [cited 2015 Jul 6]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
4. American Cancer Society. Cancer facts and figures 2015 [Internet]. Atlanta, GA: American Cancer Society, 2015 [cited 2015 Jun 3]. Available from: http://www.cancer.org/acs/groups/content/@ editorial/documents/document/acspc-044552.pdf.
5. Laursen L. A preventable cancer. Nature 2014;516:S2-3.
6. Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45:529-38.
7. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004;351:2832-8.
8. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2000;132:112-7.
9. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
10. World Cancer Research Fund International/American Institute for Cancer Research. Continuous update project report: diet, nutrition, physical activity and liver cancer [Internet]. [cited 2015 Jun 12]. Available from: http://wcrf.org/sites/default/files/Liver-Cancer-2015-Report.pdf.
11. Swinburn BA, Caterson I, Seidell JC, James WP. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr 2004;7 1A:123-46.
12. Jeffery RW, Wing RR, Sherwood NE, Tate DF. Physical activity and weight loss: does prescribing higher physical activity goals improve outcome? Am J Clin Nutr 2003;78:684-9.
13. United States Department of Agriculture and United States Department of Health and Human Services. Dietary guidelines for Americans, 2010, 7th Edition [Internet]. [cited 2015 Jun 10]. Washington (DC): U.S. Government Printing Office, 2010. Available from: http://health.gov/dietaryguidelines/dga2010/DietaryGuidelines2010.pdf.
14. Storlien LH, Huang XF, Lin S, Xin X, Wang HQ, Else PL. Dietary fat subtypes and obesity. World Rev Nutr Diet 2001;88:148-54.
15. Leamy AK, Egnatchik RA, Young JD. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res 2013;52:165-74.
16. Dekker MJ, Su QZ, Baker C, Rutledge AC, Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010;299: E685-94.
17. United States Department of Agriculture Economics Rersearch Service. U.S. per capita use of selected, commercially produced, fresh, and processing vegetables and dry pulse crops, 1970-2014 [Internet]. [cited 2015 Jul 10]. Available from: http://www.ers.usda.gov/datafiles/Vegetable_and_Pulses_Yearbook_Tables/General/YRBK2015_Section %201_General.pdf.
18. Jeffery EH, Araya M. Physiological effects of broccoli consumption. Phytochem Rev 2009;8:283-98.
19. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci EL. Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst 1999;91:605-13.
20. Voorrips LE, Goldbohm RA, van Poppel G, Sturmans F, Hermus RJJ, van den Brandt PA. Vegetable and fruit consumption and risks of colon and rectal cancer in a prospective cohort study-The Netherlands Cohort Study on Diet and Cancer. Am J Epidemiol 2000;152:1081-92.
21. Terry P, Wolk A, Persson I, Magnusson C. Brassica vegetables and breast cancer risk. JAMA 2001;285:2975-7.
22. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, et al. Vegetables, fruits, legumes and prostate cancer: a multiethnic casecontrol study. Cancer Epidemiol Biomarkers Prev 2000;9:795-804.
23. Kensler TW, Chen JG, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, Ye LX, Coady JL, Wang JB, Wu Y, et al. Effects of glucosinolaterich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev 2005;14:2605-13.
24. Reeves PG, Nielsen FH, Fahey GC, Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-51.
25. Dosz EB, Jeffery EH. Commercially produced frozen broccoli lacks the ability to form sulforaphane. J Funct Foods 2013;5:987-90.
26. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
27. Aranda PS, LaJoie DM, Jorcyk CL. Bleach gel: a simple agarose gel for analyzing RNA quality. Electrophoresis 2012;33:366-9.
28. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-8.
29. Barbisan LF, Miyamoto M, Scolastici C, Salvadori DMF, Ribeiro LR, Eira AF, de Camargo JLV. Influence of aqueous extract of Agaricus blazei on rat liver toxicity induced by different doses of diethylnitrosamine. J Ethnopharmacol 2002;83:25-32.
30. Park EJ, Lee JH, Yu GY, He GB, Ali SR, Holzer RG, Osterreicher CH, Takahashi H, Karin M. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010;140:197-208.
31. Strissel KJ, Stancheva Z, Miyoshi H, Perfield, 2nd JW, DeFuria J, Jick Z, Greenberg AS, Obin MS. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007;56:2910-8.
32. Altintas MM, Rossetti MA, Nayer B, Puig A, Zagallo P, Ortega LM, Johnson KB, McNamara G, Reiser J, Mendez AJ, et al. Apoptosis, mastocytosis, and diminished adipocytokine gene expression accompany reduced epididymal fat mass in long-standing diet-induced obese mice. Lipids Health Dis 2011;10:198.
33. Choi KM, Lee YS, Kim W, Kim SJ, Shin KO, Yu JY, Lee MK, Lee YM, Hong JT, Yun YP, et al. Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice. J Nutr Biochem 2014;25:201-7.
34. Zhu N, Soendergaard M, Jeffery EH, Lai RH. The impact of loss of myrosinase on the bioactivity of broccoli products in F344 rats. J Agric Food Chem 2010;58:1558-63.
35. Armah CN, Derdemezis C, Traka MH, Dainty JR, Doleman JF, Saha S, Leung W, Potter JF, Lovegrove JA, Mithen RF. Diet rich in high glucoraphanin broccoli reduces plasma LDL cholesterol: evidence from randomised controlled trials. Mol Nutr Food Res 2015;59:918-26.
36. Valls C, Iannacconne R, Alba E, Murakami T, Hori M, Passariello R, Vilgrain V. Fat in the liver: diagnosis and characterization. Eur Radiol 2006;16:2292-308.
37. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-40.
38. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 1990;11:74-80.
39. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343-51.
40. Su X, Abumrad NA. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol Metab 2009;20:72-7.
41. Bechmann LP, Gieseler RK, Sowa JP, Kahraman A, Erhard J, Wedemeyer I, Emons B, Jochum C, Feldkamp T, Gerken G, et al. Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis. Liver Int 2010;30:850-9.
42. Miquilena-Colina ME, Lima-Cabello E, Sanchez-Campos S, Garcia-Mediavilla MV, Fernandez-Bermejo M, Lozano-Rodriguez T, Vargas-Castrillon J, Buque X, Ochoa B, Aspichueta P, et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut 2011;60:1394-402.
43. Hussain MM, Shi J, Dreizen P. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J Lipid Res 2003;44:22-32.
44. Kohjima M, Enjoji M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med 2007;20:351-8.
45. Diraison F, Moulin P, Beylot M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab 2003;29:478-85.
46. Strable MS, Ntambi JM. Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol Biol 2010;45:199-214.
47. Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Scholmerich J, Bollheimer LC. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 2006;36:485-501.
48. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 2011;13:376-88.
49. Kim S, Sohn I, Ahn JI, Lee KH, Lee YS. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 2004;340:99-109.
50. Inoue M, Ohtake T, Motomura W, Takahashi N, Hosoki Y, Miyoshi S, Suzuki Y, Saito H, Kohgo Y, Okumura T. Increased expression of PPAR gamma in high fat diet-induced liver steatosis in mice. Biochem Biophys Res Commun 2005;336:215-22.
51. Gregoire FM, Zhang Q, Smith SJ, Tong C, Ross D, Lopez H, West DB. Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. Am J Physiol Endocrinol Metab 2002;282:E703-13.
52. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003;552:335-44.
53. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JRB, Newgard CB, et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008;7:45-56.
54. Lambertucci RH, Hirabara SM, Silveira LD, Levada-Pires AC, Curi R, Pithon-Curi TC. Palmitate increases superoxide production through mitochondrial electron transport chain and NADPH oxidase activity in skeletal muscle cells. J Cell Physiol 2008;216:796-804.
55. Cytochrome DA. P450 2E1: its role in disease and drug metabolism, 2013. Netherlands: Springer; 2013.
56. Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002;16:663-78.
57. Day CP, James OF. Steatohepatitis: a tale of two ''hits''? Gastroenterology 1998;114:842-5.
58. Kang JS, Wanibuchi H, Morimura K, Gonzalez FJ, Fukushima S. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res 2007;67:11141-6.
59. Matsuzawa-Nagata N, Takamura T, Ando H, Nakamura S, Kurita S, Misu H, Ota T, Yokoyama M, Honda M, Miyamoto K, et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 2008;57:1071-7.
60. Zhou R, Lin JJ, Wu DF. Sulforaphane induces Nrf2 and protects against CYP2E1-dependent binge alcohol-induced liver steatosis. Biochim Biophys Acta 2014;1840:209-18.
61. Barcelo S, Gardiner JM, Gescher A, Chipman JK. CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 1996;17:277-82.
62. Guo Z, Smith TJ, Wang E, Sadrieh N, Ma Q, Thomas PE, Yang CS. Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats. Carcinogenesis 1992;13:2205-10.
63. Sahin K, Orhan C, Tuzcu M, Sahin N, Ali S, Bahcecioglu IH, Guler O, Ozercan I, Ilhan N, Kucuk O. Orally administered lycopene attenuates diethylnitrosamine-induced hepatocarcinogenesis in rats by modulating Nrf-2/HO-1 and Akt/mTOR pathways. Nutr Cancer 2014;66:590-8.
64. Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol 2009;51:212-23.
65. Huang W, Metlakunta A, Dedousis N, Zhang P, Sipula I, Dube JJ, Scott DK, O'Doherty RM. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 2010;59:347-57.
66. Tosello-Trampont AC, Landes SG, Nguyen V, Novobrantseva TI, Hahn YS. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production. J Biol Chem 2012;287:40161-72.
67. Miura K, Yang L, van Rooijen N, Ohnishi H, Seki E. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol 2012;302: G1310-21.
68. Haukeland JW, Damas JK, Konopski Z, Loberg EM, Haaland T, Goverud I, Torjesen PA, Birkeland K, Bjoro K, Aukrust P. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 2006;44:1167-74.
69. Gad SC. Animal models in toxicology. 2nd ed. Boca Raton (FL): CRC/Taylor & Francis; 2007.